Grupo Cooperativo de Hemopatías Malignas
5 clinical trials · Sponsor
◉ Watch Grupo Cooperativo de Hemopatías Malignas
| Record | Firm | Date |
|---|---|---|
| Myeloid Mutations Register in R/R CML (NCT05080829) | Grupo Cooperativo de Hemopatías Malignas | 2021-03-01 |
| Treatment of SARS Caused by COVID-19 With Ruxolitinib (NCT04334044) | Grupo Cooperativo de Hemopatías Malignas | 2020-09-01 |
| Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma (NCT04288765) | Grupo Cooperativo de Hemopatías Malignas | 2020-03-01 |
| Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia (NCT04296214) | Grupo Cooperativo de Hemopatías Malignas | 2020-01-01 |
| Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia (NCT03755947) | Grupo Cooperativo de Hemopatías Malignas | 2018-12-01 |
Track Grupo Cooperativo de Hemopatías Malignas automatically
Every clearance here is in the API, with alerts when new ones post.